Quratis

Quratis Current Liabilities

The Current Liabilities of Quratis (348080.KQ) as of Oct 15, 2026 is 310.00 KRW. In the previous year, Current Liabilities was 7.94 B KRW — a change of -100.00% (lower).

Current Liabilities

310.00KRW

YoY

-100.00%

Last updated:

Current Liabilities of Quratis is 2025 310.00 KRW. Current Liabilities of Quratis was 2024 7.94 B KRW. It decreases by -100.00% lower compared to the previous year.

The Quratis Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2020
7.60 B KRW
Jan 1, 2021
11.65 B KRW
Jan 1, 2022
14.73 B KRW
Jan 1, 2023
8.17 B KRW
Jan 1, 2024
7.94 B KRW
Jan 1, 2025
310.00 KRW
The Quratis Current Liabilities history
YEARCurrent LiabilitiesYoY
310.00KRW-100.00%
7.94 BKRW-2.86%
8.17 BKRW-44.55%
14.73 BKRW+26.50%
11.65 BKRW+53.22%
7.60 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quratis Stock analysis

What does Quratis do? Quratis Inc is a biotechnology company based in Seoul, South Korea, operating within the Health Care sector. The company went public on June 15, 2023, with its stock listed under the ticker 348080.KQ and ISIN KR734808080003. Quratis focuses on research and development in the pharmaceutical industry, specifically developing medicine and pharmaceutical products. The company is involved in the manufacture and sale of vaccines and peptide nucleic acid complexes. It also provides Cell Penetrating Peptide (CPP) platform services. Quratis is engaged in the development and research of vaccines, including tuberculosis vaccines for adults and adolescents and COVID-19 vaccines. The company has 91 employees and maintains a website at http://quratis.com/. Quratis operates in the biotechnology industry, emphasizing innovation in vaccine development and pharmaceutical research. Its headquarters are located in Seoul, South Korea, and it is active in the development of novel therapeutic solutions for global health challenges. The company's activities span from research to commercialization, with a focus on advancing medical treatments through biotechnology. Quratis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quratis stock

Current Liabilities of Quratis is 310.00 KRW in 2025.

Current Liabilities of Quratis changed from 7.94 B KRW to 310.00 KRW, representing a -100.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Quratis since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Quratis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Quratis

All Key Metrics — Quratis